Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: a randomized, multi-center study.

about

Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: a randomized, multi-center study.

Item

http://www.wikidata.org/entity/Q44017644

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Efficacy and safety of weekly ...... andomized, multi-center study.

@en

Efficacy and safety of weekly ...... andomized, multi-center study.

@nl

type

Item

label

Efficacy and safety of weekly ...... andomized, multi-center study.

@en

Efficacy and safety of weekly ...... andomized, multi-center study.

@nl

prefLabel

Efficacy and safety of weekly ...... andomized, multi-center study.

@en

Efficacy and safety of weekly ...... andomized, multi-center study.

@nl

P1476

Efficacy and safety of weekly ...... andomized, multi-center study.

@en

P2093

Fei Gu

http://www.w3.org/2001/XMLSchema#string

Hua-Xiang Liu

http://www.w3.org/2001/XMLSchema#string

Jia-Long Guo

http://www.w3.org/2001/XMLSchema#string

Jin-Xia Zhao

http://www.w3.org/2001/XMLSchema#string

Li-Min Ren

http://www.w3.org/2001/XMLSchema#string

Li-Na Chen

http://www.w3.org/2001/XMLSchema#string

Li-Qi Bi

http://www.w3.org/2001/XMLSchema#string

Ling-Yun Sun

http://www.w3.org/2001/XMLSchema#string

Ping Zhu

http://www.w3.org/2001/XMLSchema#string

Ru Li

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Clinical pharmacokinetics of leflunomide

Leflunomide in the treatment of patients with early rheumatoid arthritis--results of a prospective non-interventional study

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis.

Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study.

Weekly leflunomide as monotherapy for recent-onset rheumatoid arthritis.

P304

651-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1756-185X.12677

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26268935

http://www.w3.org/2001/XMLSchema#string